Sildenafil therapy for neonatal and childhood pulmonary hypertensive vascular disease (Q82786142)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21138617%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Sildenafil therapy for neonatal and childhood pulmonary hypertensive vascular disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21138617%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

Tilman Humpl

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21138617%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Janette T Reyes

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21138617%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Simon Erickson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21138617%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Ruth Armano

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21138617%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Helen Holtby

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21138617%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Ian Adatia

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21138617%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

8 December 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21138617%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

published in

Cardiology in the Young

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21138617%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21138617%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21138617%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

187-193

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21138617%20AND%20SRC:MED&resulttype=core&format=json

Cardiovascular effects of sildenafil in neonates and infants with congenital diaphragmatic hernia and pulmonary hypertension

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001745

7 January 2021

Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension.

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001745

7 January 2021

Retinal effects of 6 months of daily use of tadalafil or sildenafil

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001745

7 January 2021

Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001745

7 January 2021

Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgery

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001745

7 January 2021

Stress Doppler echocardiography in relatives of patients with idiopathic and familial pulmonary arterial hypertension: results of a multicenter European analysis of pulmonary artery pressure response to exercise and hypoxia

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001745

7 January 2021

Recent advances in pulmonary vascular disease

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001745

7 January 2021

Long-Term Treatment With Oral Sildenafil Is Safe and Improves Functional Capacity and Hemodynamics in Patients With Pulmonary Arterial Hypertension

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001745

7 January 2021

Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001745

7 January 2021

Rebound pulmonary hypertension after inhalation of nitric oxide

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001745

7 January 2021

Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: twelve-month clinical trial of a single-drug, open-label, pilot study

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001745

7 January 2021

Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001745

7 January 2021

Intravenous sildenafil in the treatment of neonates with persistent pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001745

7 January 2021

Sildenafil prevents rebound pulmonary hypertension after withdrawal of nitric oxide in children

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001745

7 January 2021

Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001745

7 January 2021

Abnormal vascular tone in infants and children with lung hypoplasia: Findings from cardiac catheterization and the response to chronic therapy

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001745

7 January 2021

Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001745

7 January 2021

Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001745

7 January 2021

Improving the outcome of childhood pulmonary arterial hypertension: the effect of bosentan in the setting of a dedicated pulmonary hypertension clinic

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001745

7 January 2021

10.1017/S1047951110001745

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21138617%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference